Key facts
- This page summarizes Dillon Adrian T.'s Form 4 filing for HEALTHEQUITY, INC. (HQY).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 29 Jun 2026, 16:22.
Dillon Adrian T. - 25 Jun 2026 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)
- Reporting relationship
- Director
- Issuer ticker
- HQY
- Reported as of
- 25 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jun 2026, 16:22:33 UTC
- Prior SEC filing
- 30 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Newton , Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dillon Adrian T. filed Form 4 for HEALTHEQUITY, INC. (HQY) on 29 Jun 2026.
Change
- Previous filing in this sequence was filed on 30 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001163402
Primary reporting owner
DILLON ADRIAN T
- Relationship
- Director
- Address
- C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER
- Signature
- /s/ Michael Newton , Attorney-in-Fact
- Signature date
- 29 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HQY
transaction
Common Stock
Award
- Transaction value
- Shares
- +2,877
- Change %
- +4.8%
- Price
- $0.000000*
- Shares after
- 62,395
- Date
- 25 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,632
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,632
- Exercise price
- $32.50
- Footnotes
- F2
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,837
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,837
- Exercise price
- $46.40
- Footnotes
- F2
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,339
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,339
- Exercise price
- $50.41
- Footnotes
- F2
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,626
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,626
- Exercise price
- $63.64
- Footnotes
- F2
HQY
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,012
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,012
- Exercise price
- $66.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.
Footnote F2
The option is immediately exercisable.
SEC remarks
The Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission on February 5, 2024, as an exhibit to a statement on Form 4 filed by Mr. Dillon with respect to HealthEquity, Inc. and is hereby incorporated by reference.